drugset / Trial / NCT05090111
A Study of ALG-055009 in Healthy Volunteers and Subjects With Hyperlipidemia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Randomized Study of ALG-055009 Drug to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses in Healthy Volunteers and Subjects with Hyperlipidemia
Timeline
- Start
- 2021-12-01
- Primary completion
- 2023-06-16
- Completion
- 2023-06-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALG-055009 | Unknown | — | Oral |